Don't Just Read the News, Understand It.
Published loading...Updated

Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors

Summary by Weatherford Democrat
BRIDGEWATER, NEW JERSEY / ACCESS Newswire / June 17, 2025 / Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology, today announced significant appointments to its executive leadership and board of directors,…

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Weatherford Democrat broke the news in on Tuesday, June 17, 2025.
Sources are mostly out of (0)